Literature DB >> 33492383

Pore-forming toxins in infection and immunity.

Pratima Verma1, Shraddha Gandhi1, Kusum Lata1, Kausik Chattopadhyay1.   

Abstract

The integrity of the plasma membranes is extremely crucial for the survival and proper functioning of the cells. Organisms from all kingdoms of life employ specialized pore-forming proteins and toxins (PFPs and PFTs) that perforate cell membranes, and cause detrimental effects. PFPs/PFTs exert their damaging actions by forming oligomeric pores in the membrane lipid bilayer. PFPs/PFTs play important roles in diverse biological processes. Many pathogenic bacteria secrete PFTs for executing their virulence mechanisms. The immune system of the higher vertebrates employs PFPs to kill pathogen-infected cells and transformed cancer cells. The most obvious consequence of membrane pore-formation by the PFPs/PFTs is the killing of the target cells due to the disruption of the permeability barrier function of the plasma membranes. PFPs/PFTs can also activate diverse cellular processes that include activation of the stress-response pathways, induction of programmed cell death, and inflammation. Upon attack by the PFTs, host cells may also activate pathways to repair the injured membranes, restore cellular homeostasis, and trigger inflammatory immune responses. In this article, we present an overview of the diverse cellular responses that are triggered by the PFPs/PFTs, and their implications in the process of pathogen infection and immunity.
© 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  bacterial pathogenesis; immunity; infection; membranes; pore-forming protein; pore-forming toxin

Mesh:

Substances:

Year:  2021        PMID: 33492383     DOI: 10.1042/BST20200836

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

Review 1.  Membrane Dynamics and Remodelling in Response to the Action of the Membrane-Damaging Pore-Forming Toxins.

Authors:  Kusum Lata; Mahendra Singh; Shamaita Chatterjee; Kausik Chattopadhyay
Journal:  J Membr Biol       Date:  2022-03-19       Impact factor: 1.843

2.  Protein-lipid interaction at low pH induces oligomerization of the MakA cytotoxin from Vibrio cholerae.

Authors:  Aftab Nadeem; Bernt Eric Uhlin; Sun Nyunt Wai; Alexandra Berg; Hudson Pace; Athar Alam; Eric Toh; Jörgen Ådén; Nikola Zlatkov; Si Lhyam Myint; Karina Persson; Gerhard Gröbner; Anders Sjöstedt; Marta Bally; Jonas Barandun
Journal:  Elife       Date:  2022-02-08       Impact factor: 8.140

3.  Curcumin Inhibits Membrane-Damaging Pore-Forming Function of the β-Barrel Pore-Forming Toxin Vibrio cholerae Cytolysin.

Authors:  Mahendra Singh; N Rupesh; Shashi Bhushan Pandit; Kausik Chattopadhyay
Journal:  Front Microbiol       Date:  2022-01-24       Impact factor: 5.640

Review 4.  Exploring the Role of Staphylococcus aureus in Inflammatory Diseases.

Authors:  Huanquan Chen; Junyan Zhang; Ying He; Zhuoyi Lv; Zhengtong Liang; Jianze Chen; Peishan Li; Jiawei Liu; Hongchen Yang; Ailin Tao; Xueting Liu
Journal:  Toxins (Basel)       Date:  2022-07-06       Impact factor: 5.075

5.  Self-Assembly of Lipid Mixtures in Solutions: Structures, Dynamics Processes and Mechanical Properties.

Authors:  Lingling Sun; Fan Pan; Shiben Li
Journal:  Membranes (Basel)       Date:  2022-07-23

6.  Involvement of Pore Formation and Osmotic Lysis in the Rapid Killing of Gamma Interferon-Pretreated C166 Endothelial Cells by Rickettsia prowazekii.

Authors:  Jenifer Turco
Journal:  Trop Med Infect Dis       Date:  2022-08-01

7.  The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells.

Authors:  Charles M Russell; Katherine G Schaefer; Andrew Dixson; Amber L H Gray; Robert J Pyron; Daiane S Alves; Nicholas Moore; Elizabeth A Conley; Ryan J Schuck; Tommi A White; Thanh D Do; Gavin M King; Francisco N Barrera
Journal:  Elife       Date:  2022-09-29       Impact factor: 8.713

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.